PRESS RELEASE published on 11/06/2025 at 13:00, 1 year ago Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates Moderna, Inc. reports Q3 revenue of $1.0B with a net loss of $(0.2)B. Narrows 2025 revenue range and improves operating expenses. Business updates and financial results detailed Financial Results Moderna Inc. Business Updates Operating Expenses Q3 Revenue
BRIEF published on 11/03/2025 at 13:05, 1 year ago Moderna Initiates Phase 1/2 Trial for Multiple Myeloma Therapy Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
BRIEF published on 11/03/2025 at 13:05, 1 year ago Moderna lance un essai de phase 1/2 pour un traitement du myélome multiple Moderna Myélome Multiple Étude De Phase 1/2 ARNm-2808 Engager Les Lymphocytes T
PRESS RELEASE published on 11/03/2025 at 13:00, 1 year ago Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma Moderna doses first patient with mRNA-2808 in Phase 1/2 study for multiple myeloma. Targets validated myeloma-associated antigens to combat resistance mechanisms Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
BRIEF published on 10/23/2025 at 20:47, 1 year ago Moderna reconnue comme l'un des meilleurs employeurs pour la onzième année consécutive Innovation Moderne ARNm Meilleur Employeur MNEXSPIKE
BRIEF published on 10/23/2025 at 20:47, 1 year ago Moderna Recognized as Top Employer for Eleventh Year in a Row Innovation Moderna MRNA Top Employer MNEXSPIKE
PRESS RELEASE published on 10/23/2025 at 20:42, 1 year ago Moderna Named a Top Employer by Science for Eleventh Consecutive Year Moderna, Inc. named a top employer in biopharmaceutical industry by Science for 2025. Recognized for innovation, commitment, and culture Moderna Inc. Biopharmaceutical Industry MRNA Technology Top Employer Science Survey
BRIEF published on 10/23/2025 at 13:05, 1 year ago Moderna to Host Investor Event on November 20, 2025 Webcast MRNA Technology Moderna Investor Event Analyst Day
BRIEF published on 10/23/2025 at 13:05, 1 year ago Moderna organise un événement pour les investisseurs le 20 novembre 2025 Webcast Moderne Événement Pour Les Investisseurs Technologie De L'ARNm Journée Des Analystes
PRESS RELEASE published on 10/23/2025 at 13:00, 1 year ago Moderna to Host Investor Event - Analyst Day Moderna, Inc. to host Investor Event discussing development and commercial strategy. Live webcast available on website. Leading in mRNA medicine Webcast MRNA Medicine Moderna Investor Event Development Strategy
Published on 11/10/2026 at 13:30, 2 minutes ago Adcore Reports Third Quarter 2026 Results: Gross Margin Rises to 64%, Operating Loss Halved, Cash Up to $4.3 Million as Restructuring Takes Hold
Published on 11/10/2026 at 13:15, 17 minutes ago Evergold Intersects 41.0 Metres of 1.10 g/t AuEq and 31.9 Metres of 1.43 g/t AuEq on New Northern Fence, Extending Mineralization North at Golden Lion
Published on 11/10/2026 at 13:00, 32 minutes ago Zeb Nickel Commences Diamond Drilling at the Zeb Nickel Project
Published on 11/10/2026 at 13:00, 32 minutes ago Electrovaya to Participate in Upcoming Investor Conferences
Published on 11/10/2026 at 13:00, 32 minutes ago INEO Invited to 15th Annual ROTH Technology Conference in New York
Published on 11/10/2026 at 13:05, 26 minutes ago NORTON MOTORCYCLES ENTERS NEW CATEGORY WITH NEW NORTON 450 CC URBAN DEBUT AT EICMA - FULL MATERIALS NOW AVAILABLE
Published on 11/10/2026 at 13:00, 32 minutes ago Oakstone Holidays Champions Off-Season Coastal Escapes as UK Holidaymakers Rethink Seaside Breaks
Published on 11/10/2026 at 12:50, 42 minutes ago Form 8.3 - Zürcher Kantonalbank: Irish Residential Properties REIT plc
Published on 11/10/2026 at 12:45, 47 minutes ago Gabler Group AG Invites to Earnings Call on Unaudited Q3 2026 Results
Published on 11/10/2026 at 12:35, 56 minutes ago Cognizant dedicates more than 25,000 professionals to Claude delivery, introduces managed services model to run Claude at the core of enterprise operations
Published on 11/10/2026 at 11:02, 2 hours 29 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 11:02, 2 hours 29 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 6 hours 32 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 6 hours 32 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 19 hours 2 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
